Neuroendocrine Carcinoma of the Lung

• CLINICAL_TRIALS research · 2026-04-14
  Clinical Trial Update: A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate [Phase 1]

  Phase 1 study evaluating radiopharmaceutical 177Lu-DTPA-SC16.56 in neuroendocrine carcinomas of the lung and prostate; the trial is not yet …

• CLINICAL_TRIALS trial_result · 2021-04-02
  Clinical Trial Update: 3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA Trial [Phase 2]

  Phase 2 trial evaluating Pasireotide LAR and Everolimus alone or in combination for neuroendocrine carcinoma of the lung and thymus has comp…